Interferon alfa-2a

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.

For the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, and chronic myelogenous leukemia. Also for the treatment of oral warts arising from HIV infection.

• Chronic Hepatitis B Infection
• Chronic Hepatitis C Virus (HCV) Infection
• Chronic Myelogenous Leukemia (CML)
• Cutaneous T-Cell Lymphoma (CTCL)
• Hairy Cell Leukemia (HCL)
• Kaposi's Sarcoma
• Multiple Myeloma (MM)
• Non-Hodgkin's Lymphoma (NHL)
• Thrombocytosis